• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

    2.730 -0.410 (-13.06%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nautilus Biotechnology, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    Nautilus (NAUT) Q3 2026 Earnings Call Transcript ↗
    Cash reserves extend runway into early 2028 as proteoform assay pipeline accelerates. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Nautilus Biotechnology Q3 Earnings Call Highlights ↗
    Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward commercialization of its Voyager proteomics platform, with management reaffirming... 
    Via MarketBeat
    Topics Earnings
    Nautilus Biotechnology (NASDAQ:NAUT) Q3 Earnings Beat and Pipeline Progress Drive Premarket Surge ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗
    Via Chartmill
    News headline image
    Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium
    Nautilus expects to receive up to $6 million to bring its Voyager™ Platform to a multidisciplinary team integrating protein science, AI, and computational modeling to develop new diagnostics and... 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-09-29: top gainers and losers in today's session. ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
    First large-scale, single-molecule analysis of the tau proteoform landscape reveals unique disease-associated modifications, a new source of potential biomarkers and drug targets, and a method Nautilus... 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    News headline image
    Nautilus Biotechnology Q2 Earnings Call Highlights ↗
    Nautilus Biotechnology (NASDAQ:NAUT) said it is shifting a significant share of its research and development resources toward proteoform applications, citing customer interest and a delay in its... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q1 2026 Earnings Transcript ↗
    Nautilus (NAUT) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    Nautilus Biotechnology Reports First Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗
    The real brain computer interface opportunity isn’t in the headlines. These 10 stocks are building the systems that make it possible. 
    Via InvestorPlace
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Q1 Virtual Investor Summit Presentations Now Available On Demand
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
    Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗
    Nautilus (NAUT) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.